Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease (Q34728987)

4 August 2017

Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease (English)

1 reference

mild cognitive impairment

4 August 2017

0 references

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

11

Colin L Masters

1 reference

4 August 2017

8

Cassandra Szoeke

1 reference

4 August 2017

5

Robert H Pietrzak

1 reference

4 August 2017

Paul Maruff

1

1 reference

4 August 2017

Yen Ying Lim

2

1 reference

4 August 2017

David Darby

3

1 reference

4 August 2017

Kathryn A Ellis

4

1 reference

4 August 2017

Peter J Snyder

6

1 reference

4 August 2017

Ashley I Bush

7

1 reference

4 August 2017

Adrian Schembri

9

1 reference

4 August 2017

David Ames

10

1 reference

4 August 2017

AIBL Research Group

12

1 reference

4 August 2017

language of work or name

1 reference

23 December 2013

1 reference

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

1

1 reference

4 August 2017

30

1 reference

https://scigraph.springernature.com/pub.10.1186/2050-7283-1-30

4 August 2017

0 references

cites work

Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Validity of a brief computerized cognitive screening test in dementia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Working memory in mild Alzheimer's disease and early Parkinson's disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Mild cognitive impairment: clinical characterization and outcome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The Clinical Dementia Rating (CDR): current version and scoring rules

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The hospital anxiety and depression scale

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The decline of working memory in Alzheimer's disease. A longitudinal study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Mild cognitive impairment can be detected by multiple assessments in a single day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Intraindividual cognitive decline using a brief computerized cognitive screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Evaluation of the usability of a brief computerized cognitive screening test in older people for epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Reliability of repeated cognitive assessment of dementia using a brief computerized battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Aβ amyloid, cognition, and APOE genotype in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Subtle memory decline over 12 months in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Modeling hippocampal and neocortical contributions to recognition memory: a complementary-learning-systems approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

The retooling of old cognitive tests as an interim step on the path to validating a next generation of neuropsychological paradigms and assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2050-7283-1-30

Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

Rapid decline in episodic memory in healthy older adults with high amyloid-β.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4269990

26 October 2018

Identifiers

DOI

10.1186/2050-7283-1-30

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference